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A B S T R A C T
Livestock losses due to rabies and health and the corresponding benefits of controlling the disease are not often
considered when the cost-effectiveness of rabies control is evaluated. In this research, assessed the benefits of
applying a One Health perspective that includes these losses to the case of canine rabies vaccination in Ethiopia.
We constructed a dynamic epidemiological model of rabies transmission. The model was fit to district-specific
data on human rabies exposures and canine demography for two districts with distinct agro-ecologies. The
epidemiological model was coupled with human and livestock economic outcomes to predict the health and
economic impacts under a range of vaccination scenarios. The model indicates that human exposures, human
deaths, and rabies-related livestock losses would decrease monotonically with increasing vaccination coverage.
In the rural district, all vaccination scenarios were found to be cost-saving compared to the status quo of no
vaccination, as more money could be saved by preventing livestock losses than would be required to fund the
vaccination campaigns. Vaccination coverages of 70% and 80% were identified as most likely to provide the
greatest net health benefits at the WHO cost-effectiveness threshold over a period of 5 years, in urban and rural
districts respectively. Shorter time frames led to recommendations for higher coverage in both districts, as did
even a minor threat of rabies re-introduction. Exclusion of rabies-related livestock losses reduced the optimal
vaccination coverage for the rural district to 50%. This study demonstrated the importance of including all
economic consequences of zoonotic disease into control decisions. Analyses that include cattle and other rabies-
susceptible livestock are likely better suited to many rural communities in Africa wishing to maximize the
benefits of canine vaccination.
1. Background
Vaccines provide a benefit to society by eliminating, preventing or
controlling the spread of disease in the population [1]. However, vac-
cine-based control programs can involve large investments [2,3]. In
many resource-limited countries, funding such a project could be at the
expense of other competing interests such as investing in basic infra-
structure. Given these competing interests and high cost of
implementation, it is important to identify the cost-effective level of
vaccination coverage for a disease in order to avoid the drawbacks of
over or under-vaccination and to help prioritize efforts to increase
vaccination coverage [4,5].
Rabies control cost-effectiveness evaluations conducted in Africa
and elsewhere traditionally focus on a relatively narrow set of benefits,
such as averted deaths among humans [6]. Such approaches may sub-
stantially undervalue the benefit of vaccination [7], especially in
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settings where economically important animals are also afflicted. As
demonstrated in an assessment of Brucellosis control in Mongolia [8], a
more complete assessment would reflect vaccination's impact on dis-
ease in the source animal, other affected animal species, and related
economic sectors.
Rabies claims the lives of 60,000 people annually worldwide and
imposes an associated annual economic loss of 8.6 billion dollars ac-
counting for direct and indirect expenditures related to post-exposure
prophylaxis, dog vaccination expenditures, human productivity losses,
and livestock losses [9]. However, efforts to control the disease are
lacking, particularly in sub-Saharan African nations such as Ethiopia.
As> 99% of all human cases worldwide result from the bite of a do-
mestic dog [10], the World Health Organization (WHO) recommends
canine rabies vaccination to eliminate the disease in canine populations
and consequently in humans. Many countries in the Western Hemi-
sphere have significantly reduced the human rabies incidence through
large-scale dog vaccination campaigns, controlling free-ranging dog
populations and enforcing legislation for responsible pet ownership, as
well as providing rabies post-exposure prophylaxis [11]. As a result,
starting in the 1920s and 1930s, mass vaccination programs were lar-
gely responsible for the elimination of dog rabies and reducing the
annual incidence of human rabies to almost zero in North America,
while the number of cases in Central and South America as well as the
Caribbean have decreased markedly [12–14].
In Ethiopia, canine vaccination has never been enforced as com-
pulsory nor promoted as a public good, and as such very few dog
owners vaccinate their dogs in the country [15,16]. In addition to
threatening humans, rabies incidence in cattle in Ethiopia and asso-
ciated economic losses are estimated to be one of the highest globally
[9]. Almost all cattle rabies incidence in Ethiopia were also attributed
to suspected rabid dog bite. Cattle are one of the most important and
numerous livestock species in Ethiopia, representing a major source of
animal protein and providing draft power to support crop farming, in
addition to other socio-cultural roles [17]. Herd-level incidence has
been shown to vary based on agroecology and cattle productions system
[18]. The impact of rabies is most substantial for pastoral cattle-keeping
households due to their complete dependency on livestock for their
livelihoods.
To identify the economically optimal program for rabies control in
Ethiopia, there is a need for an overarching One-Health oriented cost-
effectiveness analysis that includes rabies-related livestock losses in
cattle-keeping communities. We present the first cost-effectiveness
model of rabies vaccination that combines human health outcomes and
livestock losses. The model is tailored to two districts of Ethiopia with
distinct agro-ecology, using parameters derived from case investigation
of human and cattle exposures to rabid dogs in each setting.
2. Materials and methods
2.1. Epidemiological model
We adapted a previously developed canine rabies transmission
model encompassing dogs and human with an extension to incorporate
cattle in a One-Health concept [19]. We applied canine demographic
parameters specific to Ethiopia, and fit epidemiological parameters to
district-specific, retrospective data on human rabies exposures and
deaths using a Bayesian Monte-Carlo Markov chain (MCMC) process.
A stochastic compartmental rabies transmission model was con-
structed for domestic dogs (Fig. 1). The canine population (N) is divided
into five classes: susceptible (S), exposed (E), infectious (I), and vacci-
nated (V). Dogs are born into the vaccinated class at rate bv(S+V+E),
and into the susceptible class at a rate b(1-v)(S+V+E). Infectious and
exposed dogs were excluded from the reproductive rate, as the virus
typically has a short incubation period and puppies born to rabid ani-
mals are unlikely to survive [19]. Upon exposure to rabies, dogs move
to the exposed class at rate βSI/K, where K is the carrying capacity and
β is the dog-to-dog daily transmission rate. The dog-to-dog transmission
rate approximates the daily number of new canine exposures resulting
from a single infectious dog and does not have a geographically-linked
component. Exposed dogs transition to the infectious class at rate σ.
Death from rabies occurs at rate α. Death from all other causes, ex-
cluding rabies but including carrying capacity and resource constraints,
removes animals from all compartments, proportional to compartment
size, at a density-dependent death rate γ that increases as the popula-
tion size approaches its carrying capacity, K, according to the Verhulst
logistic equation [20].
Transmission dynamics model equations= + +dS dt v b S E V S I K S N/ (1 ) ( ) /
=dE dt S I K E E N/ /
=dI dt E I I N/
= + +dV dt v b S E V V N/ ( )
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Humans and cattle are dead-end hosts and are exposed to rabid dogs
at rates ε and ω, respectively. We used the dog-to-human rabid biting
rate calculated by empirical studies in Tanzania [19,21], assuming that
rabid dog behavior is not markedly different across settings. Following
human exposure, a person receives sufficient doses of post-exposure
prophylaxis (PEP) with probability p. We assume all recipients of PEP
survive, but that non-recipients have a probability m of death, which is
conditional on the distribution of bite wounds across the body and the
probability of death associated with exposure to each wound type. For
the transmission to rate to cattle, ω, value was assumed. The prevalence
of cattle under any dog rabies vaccination coverage is proportional to
the reduction in dog rabies incidence, for coverage ranging from zero
(status quo in Lemuna-bilibilo) to 90%. Thus, the economic loss in
cattle was estimated accordingly. In other words, we assumed a re-
lationship between rabid dogs and rabies-related livestock loss (ω), to
be linear relationship across predictions for vaccination coverages as-
sumed. Therefore, rabies-related livestock losses will rise or fall in
concert with the incidence of canine rabies. Subsequent reduction of
dog rabies by increasing dog vaccination coverage was assumed to re-
duce the incidence in cattle by the same proportion (estimated from
Jibat and colleagues [22])and thus reduce the economic loss from cattle
rabies.
2.2. Model parameterization and fitting
We used a Bayesian Monte-Carlo Markov chain (MCMC) process to
fit the epidemiological and demographic parameters to district-specific
empirical data on human rabies incidence and canine population size.
Flat priors were specified for β, the dog-to-dog rabies transmission rate,
and K, the canine population carrying capacity. For all other para-
meters, prior distributions were defined with empirical data, either
collected specifically for this study or published in the literature
(Table 1). As several parameters differ between districts, fitting was
conducted separately for each district.
The per capita birth rate of dogs (b) was assumed to be the product
of the sex ratio (h), the average litter size (l) and litter frequency (f), and
pup survival (s) [9]. A district-specific sex ratio was estimated from a
field survey conducted in both districts in April and May 2015.
Canine density was estimated from the same survey which used
techniques of capture-mark and resights [23]. Assuming similarities
between the agro-ecologies, we derived estimates of litter size, litter
frequency, and pup survival from studies in Tanzania. Prior distribu-
tions for the rabies incubation period, 1/σ, and the infectious period, 1/
α, and the dog-to-human bite rate, δ, were also derived from Tanzania
[21].
District-specific human rabies exposures and death cases were
T.J. Beyene, et al. One Health 8 (2019) 100103
2
collected from health centers in both districts from Sept 2013 through
August of 2014 [24]. Contact tracing further identified victims who did
not report to health centers through “snowballing” exercise. Exposures
and deaths from potentially rabid dogs were identified using six ret-
rospective diagnostic criteria for the biting dogs [25]. In Bishoftu, 189
human exposures and 1 death, and in Lemuna-Bilbilo, 189 likely human
exposures and 8 deaths were identified to be from potentially rabid
dogs. With this survey data, we set the prior distribution for the post-
exposure prophylaxis probability p as Beta (147, 42) for Bishoftu and
Beta (95, 94) for Lemuna-Bilbilo. We drew from a multinomial dis-
tribution characterizing wound location and assumed Beta distributions
for wound-specific probabilities of developing rabies and then death
from our previous study [24] and from Tanzania [26].
We constructed a likelihood function to evaluate the probability of
the data on human exposure, human death, and canine population size,
using Poisson distributions around the human exposure and death data
and a normal distribution around canine population size. For each
district:
=L x d n q µ e
x
µ e
d q
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where L is the likelihood of x, d, n, and q given λ, μ, and ϕ. X is the
number of human rabies exposures, d is the number of human deaths, n
and q are the mean and standard error for canine density. The para-
meters λ, μ, and ϕ represent the model estimates for annual human
rabies exposures, annual human rabies deaths, and canine density re-
spectively.
The differential equations underlying the SEIVR model were solved
in continuous time in R statistical program using the package
“deSolve”. For each district, we used the Metropolis-Hasting algorithm
[27] to generate four chains of 20,000 iterations each, initialized at
dispersed values for β and K. We applied the Gelman-Rubin diagnostic
[28] in the R package “coda” [29] to test for convergence. We thinned
each chain by a factor of 15 and combined the final 250 parameter sets
from each thinned chain to create each district-specific joint posterior
distribution. The parameter set in the joint distribution with the highest
likelihood was designated as the representative set and used for base-
case analyses.
2.3. Human rabies exposure data collection and contact tracing
A retrospective case study was conducted to compile data on the
incidence of human rabies exposure over the period of one year
(September 2013 to August 2014) through an extensive bite case search
in the two districts of Ethiopia. Animal bite victims were traced using
Fig. 1. Rabies transmission model schematic.
(b= birth rate; γ= death rate; β= dog-to-dog transmission rate; σ= transition rate to the infectious class, α= rate of death from rabies; ε=human exposure rate
to rabid dogs; ω= cattle exposure rate to rabies; p= probability of exposed human receives sufficient doses of the post-exposure prophylaxis (PEP); v= proportion
of susceptible dogs vaccinated, m=probability of death after exposure in non-recipients of the PEP)
Table 1
Rabies transmission dynamics model parameters, distribution, prior/initial input estimates.
Parameters Description Distribution Estimate Source
Bishoftu/Urban Lemuna-bilbilo
β Dog to dog bite rate/day normal 0.42 0.4 [19]
K Carrying capacity (dogs/km2) logistic 340 35.4 Field survey
b Birth rate/day normal 0.0015 0.0011 Field survey; [19]
1/σ Incubation period (in days) normal 22.3 22.3 [19]
1/α Infectious period (in days) gamma 3.1 3.1 [19]
v Vaccination coverage 0 18% Field survey
Dog density/km2 normal 340 35.5 Field survey
ε Human bite rate/rabid dog normal 0.51 0.51 [19]
Human density/km2 3500 158 [37]
Human exposure/year 189 189 [24]
Number of human deaths/year 1 8 [24]
p Probability to receive sufficient doses of PEP* beta 0.77 0.5 [24]
(1-p)m Probability of death due to rabies multinomial 0.16 0.15 [24,26]
District size (in km2) 40 1184 [37]
ω Cattle bite rate/rabid dog – – 1.38 –
PEP*=Post Exposure Prophylaxis.
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data collected from the recorded cases at health centers as well as by
information obtained from questioning the local community to trace
unregistered bite cases. After the tracing, both registered and un-
registered case, victims (and their family) were contacted and ques-
tioned about their use of PEP, if the victim died after the bite, the in-
curred costs and the behavioral manifestation of the biting animal.
Based on these data the health burden of people who were bitten by
potentially rabid dogs was assessed as well as the costs of the applied
post-exposure prophylaxis. A detailed description of the human health
burden and costs of treatment following rabies exposure is published
elsewhere [24].
2.4. Economic model
We evaluated the total costs of rabies under each strategy consisting
of the costs associated with the vaccination campaign, human post-
exposure prophylaxis (PEP), and the rabies-related cattle losses.
2.4.1. Vaccination campaign costs
The costs of canine vaccination were based on a previously stan-
dardized economic model [30]. Accordingly, the costs of mass canine
vaccination include the costs of the vaccine, consumables (needle and
syringe, ice bar, disinfectant and swab, certificate and collar), tem-
porary vaccinators and supervisors (per-diem, training, and transporta-
tion), advertising, and capital costs (refrigerator, muzzle, and cool
bags). We assumed that a short-acting canine rabies vaccine currently
produced by the National Veterinary Institute in Ethiopia would be
purchased at its currently proposed price and would provide at least
one year of full protection. Other costs of the vaccination campaign
were established through a market survey. We incorporated increasing
dog search costs for coverage rising above 50% in both districts. We
also incorporated additional transportation costs at low coverage below
50% in Lemuna-bilbilo, as teams must travel longer distances between
villages/dogs to ensure even geographic distribution of vaccinated
dogs. Detailed procedures of costs estimation for dog vaccination
campaigns and inputs are listed in Supplementary information.
2.4.2. Human health and economic burden
We quantified the human rabies burden in terms of both the costs of
treating rabies-exposed people with PEP as well as the disability-ad-
justed life years (DALY) incurred from rabies mortality. PEP costs
consist of health care costs for wound care, tetanus anti-toxin and post-
exposure prophylaxis vaccine, as well as the non-healthcare costs of lost
productivity for the victim and any accompanying family associated
with seeking care [31]. Our previous study [32] estimated that the
average PEP costs for individuals who completed the regimen re-
commended by the Ethiopian Public Health Institute [33] were $23.2
and $30.4 in urban and rural districts, respectively.
To estimate the health burden, we considered only years of life lost
(YLL) by individuals who developed rabies. We did not consider mor-
bidity (temporary disability) as the disease is acute and swiftly fatal
[34]. We estimated the YLL per human rabies case from the primary
data on age from rabies deaths in each district, assuming a multinomial
distribution across 5-year age intervals. The average years of life lost
incurred per human rabies death was calculated by multiplying the
number of deaths within an age category multiplied by the life ex-
pectancy of the age group (i). The average life expectancy for Ethiopia
is derived from the life table estimate of 2013 as published by WHO
[35].
We calculated the PEP costs per rabid dog as the product of the rate
at which a rabid dog bites a human (δ), the post-exposure prophylaxis
probability (p), and PEP costs. Similarly, the health burden per rabid
dog was estimated by multiplying the probability of a rabid dog biting a
human (δ), a probability that the victim will not receive sufficient
treatment (1-p) and the life-years lost per human rabies death. To es-
timate the total health and economic costs of rabies under each canine
vaccination strategy, we multiplied these per-rabid-dog losses by the
number of rabid dogs in the epidemiological model predictions.
2.4.3. Costs of cattle rabies
In rural Ethiopia, the economic impact of rabies is largely mediated
by cattle exposure. Nearly all cattle rabies exposures are from rabid
dogs and canine vaccination is currently non-existent [36]. Because
cattle are dead-end hosts and not active members of the rabies trans-
mission cycle, we assumed that cattle rabies is linked directly to canine
rabies. Following the model fit, we calculate a relationship between
rabid dogs and rabies-related livestock loss (omega), and then hold this
linear relationship constant across predictions. Therefore, rabies-related
livestock losses will rise or fall in concert with the incidence of canine
rabies. Specifically, the cattle rabies-related economic loss under status
quo (Lsq) equals the product of herd-level rabies incidence (Hinc) under
status quo, the number of herds in the district (Nherd), and the eco-
nomic loss per affected herd (Lpah). Under a specific canine vaccination
strategy, this product is modified by the proportion of dogs which are
rabid compared to the status quo (rabid ∝). Economic parameters and
status quo cattle rabies incidence were extracted from our previous
study on the economic impact of cattle rabies as described in the sup-
plementary information.
2.4.3.1. Interventions. For each district separately, we simulated annual
rabies mass vaccination campaigns, at coverage varying from the status
quo to 90% in increments of 10%. Annual canine vaccination
campaigns were assumed to be delivered once a year under an
intensive campaign executed within a few days or weeks per district.
We also assumed previously vaccinated dogs would be revaccinated,
and that no waning from an initial vaccine efficacy of 100% would
occur within the year. We compared two districts in Ethiopia, Bishoftu,
and Lemuna-bilbilo which were, representative of two quite different
degrees of urbanization in Ethiopia. Bishoftu is an urban district with a
human density of 3500 inhabitants/km2 an average canine density of
340 dogs/km2, and a human rabies exposure rate of around 135 rabid
dog bites per 100,000 inhabitants. There are no cattle raised outdoor in
this urban district and cattle exposure to rabies was assumed negligible
in Bishoftu. Lemuna-bilbilo is a rural district, substantially less dense
than Bishoftu at 158 inhabitants/km2 [37], an average dog density of
35.4 dogs/km2 and a human rabies exposure rate of around 100 per
100,000 inhabitants [32,38]. Cattle exposure to rabies was assumed
mainly from domestic dogs with an average incidence of 2% and 21% at
cattle and herd level respectively [18].
2.4.3.2. Simulation of cost-effectiveness. We conducted a cost-
effectiveness evaluation to identify the most efficient strategies for
rabies control in Ethiopia. To do so, the epidemiological model was
integrated with an economic model that estimated human and cattle
rabies-related costs as well as canine vaccination campaign costs. The
integrated model was simulated over 5 years for two districts in
Ethiopia: Bishoftu and Lemuna-bilbilo, tailoring the analyses to urban
and rural settings. The canine vaccination campaigns varied from the
status quo (i.e. current vaccination coverage of 18% in urban and no
vaccination in rural districts) to 90% coverage, quantifying the impact
of each level of coverage on human exposure, health burden (DALY),
health costs, cattle related economic loses and campaign costs. The
district-specific optimal strategy, i.e. the strategy with the highest net
health benefit at a given willingness-to-pay threshold, was chosen based
on cost-effectiveness thresholds recommended by WHO which is up to 3
times the GDP per capita [39]. All base case analyses were conducted
on a time frame of 5 years with time value of money set at a 3%
discount rate, as recommended by the World Bank Disease Control
Priorities Study and the Global Burden of Disease project [40].
With the base-case predictions for each district, we first identified
the non-dominated vaccination strategies or those for which greater
health benefits could not be achieved at a lower cost per life-year. We
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then calculated the incremental cost-effectiveness ratio (ICER) of
moving from one specific canine vaccination coverage to the next most
costly non-dominated coverage. Those strategies with a cost-per-DALY
falling at or below Ethiopia's per-capita GDP of $568 [41], or three
times this value (i.e. $1704), were considered “very cost-effective” or
“cost-effective,” respectively [39].
To incorporate parameter uncertainty into our identification of the
optimal rabies control strategies, we also applied a net health benefit
(NHB) framework [42]. Net benefits are calculated for a given strategy
as the difference between the health benefit (in DALY) provided by that
strategy and its associated campaign costs compared to status quo, di-
vided by the societal willingness-to-pay for DALYs. This framework
gives a single outcome measure that identifies the strategy which pro-
vides the largest overall benefit at the given willingness-to-pay. For
each of 1000 parameter sets drawn, we identified the strategy that
conferred the highest net benefits at a value of willingness-to-pay set to
three times the GDP per capita. We then tabulated the probability that
each strategy would confer the highest net benefits, with the strategy
associated with the highest probability being considered “optimal” at
that threshold [43]. We conducted this analysis across societal will-
ingness-to-pay thresholds which is assumed to be a proxy of willingness
to pay in a potentially realistic range from $1 to $5000 per DALY saved.
2.4.3.3. Sensitivity analyses. A series of one-way sensitivity analyses
were performed using the net benefits framework, assessing the
sensitivity of the optimal strategy choice to changes in dog rabies
vaccine price, number of dogs vaccinated daily per vaccinator team,
training and advertising costs during vaccination campaign, post-
exposure prophylaxis (PEP) costs, and cattle rabies herd level
incidence. For each, the specific input parameter was adjusted to its
alternative point estimate, maintaining the base case for all other
parameters. Two-way sensitivity analyses were similarly performed on
the time frame and discount rate.
For the rabies transmission parameters, we also performed sensi-
tivity analyses around the bite rate and the probability of rabies re-
introduction through rabid dogs from neighboring villages. We as-
sumed a lower (0.20) and a higher (0.99) rabid dog-human bite rate in
cases where rabid dogs were killed or not killed and consequently had a
lower or higher chance to bite humans, respectively. Considering the
possibility of rabies reintroduction from neighboring villages, we as-
sumed that an equivalent of 1% and 3% of the rabid dogs were re-
introduced to the districts every year. For each scenario of re-in-
troduction, the MCMC process was re-fitted and run with the new
parameters, so that optimal coverage around the incremental cost-ef-
fectiveness ratios could be re-estimated.
3. Results
3.1. Estimated model parameters
3.1.1. Estimation of epidemiological parameters and model validation
Fitting the rabies epidemiological model to the data, the most likely
carrying capacities for dogs (K) were estimated to be 361 dogs/km2
(95% CI: 346–367) and 42.6 dogs/km2 (95% CI: 41.8–45.2), for the
Bishoftu and Lemuna-bilbilo districts respectively. The predicted dog-
to-dog transmission rates (β) were estimated to be 0.46 (95% CI:
0.39–0.47) and 0.40 (95% CI: 0.37–0.44) daily transmission events per
rabid dog, and the dog-to-human bite rate (δ) estimated as 0.50 (95%
CI: 0.45–0.56) and 0.56 (95% CI: 0.46–0.57) transmission events per
rabid animal, in the Bishoftu and Lemuna-bilbilo districts. The in-
cubation period (1/σ) was estimated to be 22.5 (95% CI: 20.0–24.6)
and 21.6 (95% CI: 19.8–24.8) days, while the infectious period (1/α)
was 3.13 (95% CI: 2.85–3.40) and 3.08 (95% CI: 2.88–3.35), for
Bishoftu and Lemuna-bilbilo respectively. The probability of human
developing rabies following exposure and without treatment was 0.16
(95% CI: 0.14–0.17) in both districts. The post-exposure prophylaxis
coverage was estimated to be 0.80 (95% CI: 0.74–0.84) and 0.59 (95%
CI 0.45–0.59), for the Bishoftu and Lemuna-bilbilo districts respectively
(Table 2).
The joint posterior distribution produced estimates of human rabies
exposure consistent with the data from each district in terms of ex-
posure but higher predicted deaths. In Bishoftu, the predicted a number
of human exposures (95% CI: 172–187) 179 annual and 4.6 deaths
(95% CI: 3.87–7.79 deaths), compared with the observed levels of 189
exposures and one death. In Lemuna-bilbilo the model predicted 184
annual human exposures (95% CI: 183–187) and 11.2 deaths (95% CI:
10.0–17.7), compared with the observation of 189 exposures, and 8
deaths. Under status quo coverage, the fitted epidemiological model
estimated the annual number of rabid dogs to be 340 (95% CI:
336–345) and 331 (95% CI: 326–335) in the Bishoftu and Lemuna-
bilbilo districts respectively.
3.2. Human rabies exposure predictions
The model predicted the number of rabid dog cases and conse-
quently, predicted the human exposure to decrease monotonically as
vaccination coverage increased. In Bishoftu, the mean annual number
of rabid dogs predicted to decline to 1.5 (95% CI: 0–6.89) at 90%
coverage. In Lemuna-bilbilo, the mean annual number of rabid dogs
dropped to 0.84 (95% CI: 0–3.78) at 90% coverage. In Bishoftu, all
vaccination campaigns above 40% coverage lead to fewer than 1 rabid
dog annually by the end of 4 years, while in Lemuna-bilbilo coverage
above 20% leads to fewer than 1 rabid dogs annually by the end of
4 years. In both districts, high coverage achieves faster reductions in
rabies than low coverage (see Supplementary information). In urban
Bishoftu, for the status quo (18%) and 90% coverage, the cumulative
number of human exposures over 5 years were 876 and 4.0. Similarly,
in the rural district, the cumulative number of human exposures over
5 years were 922 and 3, under the status quo (0%) and 90% coverage
conditions, respectively (Fig. 2a–b).
3.3. Human health burden in DALY lost
As human deaths are the consequence of delay or failure to receive
Table 2
Posterior distribution of epidemiological parameters.
Parameters Description MLa estimates and 95% CI
Urban/Bishoftu Rural/Lemuna-bilbilo
β dog to dog transmission/day 0.46 (0.39–0.47) 0.40 (0.37–0.44)
K Carrying capacity (dogs/km2) 361 (346–367) 42.6 (41.8–45.2)
1/σ Incubation period (days) 22.5 (19.9–24.6) 21.6 (19.8–24.8)
1/α Infectious period (days) 3.13 (2.85–3.40) 3.08 (2.88–3.35)
δ Rabid dog-human bite rate 0.50 (0.45–0.56) 0.56 (0.46–0.57)
m Probability of developing rabies 0.16 (0.15–0.17) 0.16 (0.15–0.17)
p Post-exposure prophylaxis coverage 0.80 (0.74–0.84) 0.59 (0.45–0.59)
a ML=maximum likelihood.
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an appropriate PEP, these deaths were predicted to decrease pro-
portionately with reduced canine rabies incidence as canine vaccination
coverage increased. Adjusting for district-specific data on the age of
death, a single human death corresponded to 46.7 (95% CI: 46.7–46.7)
and 50.6 (95% CI: 46.2–54.9) DALYs in Bishoftu and Lemuna-bilbilo,
respectively. Adjusting further for PEP access, each rabid dog was as-
sociated with estimated values of 0.74 and 1.67 DALYs. The cumulative
number of DALYs over 5 years under the status quo and 90% coverages
were 911 and 4 for Bishoftu and 7402.6 and 2.72 for Lemuna-bilbilo
districts respectively.
Fig. 2. Total number of human rabies exposures over 5 years for each vaccination coverage in a) Bishoftu and b) Lemuna-bilbilo under different canine vaccination
coverage strategies.
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3.4. Economic burden of rabies and costs of intervention strategies
Under the status quo, the mean annual costs for rabies control in
Bishoftu (including canine vaccination and PEP) was estimated to be
$8562 ($214/km2). This mean annual costs reached a maximum of
$19,332 ($483/km2) under 90% coverage and a minimum of
$6902($172/km2) under 20% coverage. With the increase in vaccina-
tion coverage, the cost of PEP decreased whereas the costs of dog
Fig. 3. Cost components and average annual (undiscounted) costs of rabies across different vaccination coverage in a) Bishoftu and b) Lemuna-bilbilo. NB: The scales
on the y-axis are different as the average annual costs of rabies in Bishoftu has a maximum of about $20,000 whereas Lemuna-bilbilo has a maximum of $2,500,000.
T.J. Beyene, et al. One Health 8 (2019) 100103
7
vaccination increased. The total annual costs increased monotonically
when coverage rose above 20%, as vaccination campaign costs outstrip
any savings from reduced PEP use (Fig. 3a). In Bishoftu, the urban
district, the vaccination coverage of 20% was the cheapest of all sce-
narios and the total cost was found to be majorly function of the dog
vaccination campaign.
In Lemuna-bilbilo, besides the costs of providing PEP, the economic
losses due to cattle rabies declined with an increase in vaccination
coverage as a result of a declining incidence in canine rabies (Fig. 3b).
The mean annual costs of rabies under status quo (no vaccination) was
estimated to be $2,443,572 ($2055/km2), consisting of $3331 ($2.8/
km2) PEP-related expenditures, and $2,440,241 (2052/km2) of eco-
nomic losses due to cattle rabies. The lowest cost strategy which in-
cludes the sum of losses and expenditures was shown to be at 60%
coverage. All vaccination strategies had lower total costs compared to
the cost of the status quo situation with no vaccination.
3.5. Incremental cost-effectiveness ratios
Canine vaccination coverage rates of 20% in Bishoftu and 60% in
Lemuna-bilbilo resulted in a higher reduction in DALYs for lower costs
than campaigns that adopted alternate levels of vaccination at lower
coverages. Accordingly, coverage less than these levels in each re-
spective districts is considered dominated. A dominated strategy is one
which provides fewer health benefits than other strategies of equal or
lesser cost. Each coverage also represents the minimum cost strategy for
each district. WHO-recommended thresholds for “very cost-effective”
and “cost-effective” strategies in Ethiopia to be equal to $568 and
$1710 per DALY saved, respectively. According to these thresholds,
vaccination coverages of below 50% and 70% are very cost-effective in
Bishoftu and Lemuna-bilbilo respectively. In Lemuna-bilbilo, vaccina-
tion coverage between 60% and 70% would be the only cost-effective
strategy, as the ICER associated with moving from 70% to 80% cov-
erage exceeds the WHO-recommended threshold (Table 3).
3.6. Net Health Benefit uncertainty analysis
Incorporating parameter uncertainty, we assessed the probability
that each strategy would be optimal (i.e. provide the highest net health
benefits) across a range of willingness-to-pay values (Fig. 4). We found
that coverages of 70% and 80% were the most likely to be optimal at
the “cost-effective” threshold in Bishoftu and Lemuna-bilbilo districts,
respectively (Fig. 4a and b). At the “very cost-effective” threshold, the
optimal coverage drops to 50% for Bishoftu and to 70% in Lemuna-
bilbilo. We found zero probability that the status quo would be op-
timal/recommended at all willingness-to-pay values in both districts. In
Bishoftu and Lemuna-bilbilo districts, 70% and 80% vaccination cov-
erages were the recommended/optimal choice at a likelihood of about
0.62 and 0.59, respectively.
To allow direct comparisons with Bishoftu, we analyzed a scenario
for Lemuna-bilbilo where we considered only human health and eco-
nomic benefits, excluding the economic benefit of cattle rabies. We
found that the recommended/optimal coverage would drop to 50% at a
cost-effective threshold (Fig. 4c).
3.7. Sensitivity and scenario analyses
We investigated how the recommended strategy, i.e., the strategy
most likely to be optimal at the cost-effectiveness threshold, would shift
in response to changes in economic parameters. For both districts, the
recommended strategy was found to be sensitive to vaccine price and a
number of dogs vaccinated per team but not to PEP costs, or vaccination
campaign training and advertising costs. If the price of a canine vaccine
increases from the baseline of $0.55 to beyond $1 per dog, the re-
commended coverage declines and if the number of dogs vaccinated per
day per team increases, the recommended coverage will increase. The
recommended strategy in Lemuna-bilbilo was also sensitive to the herd-
level cattle rabies incidence and required higher coverage at increased
annual cattle herd level incidence levels beyond the 20% estimated
baseline incidence (see supplementary information: Fig. 3:a-d).
The two-way scenario analyses indicated that using a shorter time
frame for analysis (3 yrs) coupled with a higher discounting rate (5%)
would shift the recommended strategy towards 90% coverage in both
districts. A longer time frame (10 yrs) and a lower discount rate (1%)
altered the recommended coverage to 50% (see supplementary in-
formation: Fig. 4a–d).
The scenario analysis revealed that the recommended coverage for
Bishoftu remains 70% across rabid dog biting rates ranging from 0.2 to
0.99 humans per rabid dog. For Lemuna-bilbilo, optimal coverage drops
to 70% at the lower biting rate (see supplementary information: Fig. 5:
a-d). Similarly, the recommended coverage shifts to 80% and 90% in
Bishoftu when rabid dogs are introduced at a percentage equivalent to
Table 3
Cumulative costs over 5 years, and discounted to present value (3% discount rate) in a) Bishoftu and b) Lemuna-bilbilo districts.
Vaccination coverage Cost of vaccination ($) Cost of PET ($) Cattle rabies related loss ($) DALY saved Total economic burden ($) ICER ($/DALY)a
a) Bishoftu
0.18 26314 16500 0 NA 42814 NA
0.2 29149 5363 0 580 34512 Minimum cost
0.3 38111 1589 0 777 39700 26
0.4 47033 719 0 822 47752 178
0.5 55939 401 0 839 56340 519
0.6 66104 248 0 846 66352 1254
0.7 76265 163 0 851 76428 2260
0.8 86425 110 0 854 86535 3717
0.9 96584 77 0 855 96661 5764
b) Lemuna-bilbilo
0 0 15715 11510855 NA 11526570 NA
0.1 82010 2133 1559457 2601 1643601 Dominated
0.2 109311 930 677651 2832 787891 Dominated
0.3 136622 517 375654 2911 512793 Dominated
0.4 160792 322 234043 2948 395157 Dominated
0.5 187845 215 155583 2969 343643 Dominated
0.6 222181 148 107638 2981 329968 Minimum cost
0.7 256517 105 76419 2990 333042 373
0.8 290853 76 55187 2995 346117 2331
0.9 325189 56 40300 2999 365545 4938
a ICER value for dominated strategies is not displayed.
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Fig. 4. Acceptability curves, showing the probability that each strategy would be optimal across a range of cost-effectiveness threshold for a) Bishoftu b) Lemuna-
bilbilo district including cattle-related losses c) Lemuna-bilbilo district excluding cattle-related losses. (Dashed line indicates WTP based on 1× Ethiopia's per-capita
GDP of 568$ (left) and 3× (i.e. $1704) (right).
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1% and 3% of current canine rabies respectively. For Lemuna-bilbilo
district, the recommended coverage increased to 90% and remained the
same for reintroduction equivalent to 1% and 3% of current canine
rabies (see supplementary information: Fig. 6: a–d).
4. Discussion
We used the example of canine vaccination against rabies to eval-
uate the broader benefits which stem from controlling vaccine-pre-
ventable zoonotic diseases. Using the One Health paradigm, we created
a unified framework that integrated the cross-sectoral burden of rabies,
including human disease, medical costs, and cattle rabies-related eco-
nomic losses in Ethiopia. This cost-effectiveness analysis is the first
study to include cattle rabies-related losses, a component which has
particular importance for livestock-dependent communities. Previous
canine vaccination evaluations in Africa and elsewhere have focused
primarily on the prevention of human rabies [6,19,44–48]. These stu-
dies indicated that high canine vaccination coverage would be cost-
effective on the basis of the human health burden alone. These studies
indicated that high canine vaccination coverage would be cost-effective
on the basis of the human health burden alone. By contrast, we found
that the inclusion of livestock costs is required in order for high cov-
erage to be cost-effective in rural Ethiopia. A recognition of these
broader benefits justifies campaigns at 80% coverage, compared to 50%
coverage when only human health outcomes are considered.
Under an ideal situation without re-introduction, our base case
analysis recommends canine vaccination campaigns at coverage of 70
and 80% for the Bishoftu (urban) and Lemuna-bilbilo (rural) districts,
respectively. These levels are consistent with the WHO recommenda-
tion of 70% coverage, which aims to eliminate rabies without con-
sidering the costs of control [49]. For the rural districts, Lemunabilbilo,
the required coverage was higher than that needed in the urban district.
This was primarily due to the fact that livestock rabies-related costs
serve as an additional incentive to increase the vaccination coverage by
10% in rural districts. While a rabies control program helps to control
the disease in the dog population and thus in humans, it would not
eliminate rabies from the population. Thus, there is a need for the
program to sustainably run for a long time as rabies otherwise could be
reintroduced from the adjacent uncontrolled neighbors i.e. both vac-
cination in dogs and PET would need to be maintained over a prolonged
time period because of rabies in adjacent districts. Hence, our sensi-
tivity analysis highlights the fact that when the optimal coverage was
simulated over a longer period (of 10 years) coverage level lower than
that recommended by the WHO could be adopted. This result suggests
that rabies control could be efficiently achieved by adopting an in-
tensive program over a shorter period of time, possibly followed by a
less intensive (i.e. lower coverage) program sustained over a longer
period of time, as has been suggested elsewhere [50]. A fuller analytical
exploration and optimization exercise involving a range of these com-
binations in Ethiopia or other resource-constrained contexts would be a
valuable contribution to rabies control policy.
Despite the public health burden of rabies and availability of an
effective vaccine, surveys throughout Ethiopia have indicated that the
current canine vaccination practices are far below anything close to
these optimal coverage levels [15,51]. In rural Lemuna-bilbilo, the
current status quo of non-existent vaccination is costly than any of the
vaccination strategies evaluated, due to the high cattle rabies-related
losses. One of the reasons for such low coverage could be the perceived
cost of vaccination campaigns and lack of evidence on the cost-effective
level of control. This economic analysis would provide a strong in-
centive for immediate action on canine rabies vaccination in rural
Ethiopia, as the entire financial investment will be recouped. In urban
Bishoftu, canine vaccination represents a financial outlay, but with a
very efficient return on investment in terms of human health. In com-
parison with cost-effectiveness estimates per DALY for providing PEP in
sub-Saharan Africa, the ICERs presented here may seem high. However,
as canine vaccination is being added to the existing PEP infrastructure,
rather than replacing it, these relatively higher cost-effectiveness ratios
are not unexpected. In addition, as PEP is less accessible for most parts
of rural Ethiopia, canine vaccination is critical to save human lives.
Canine vaccination is a one-time (or at most periodically scheduled)
campaign-based operation, while PEP services require continuous year-
round activity and the cold chain for the post-exposure prophylaxis
vaccine as exposure may happen at any time.
Although we incorporated parameter uncertainty into our analysis
whenever possible, it was necessary to make some parameter assump-
tions. Currently, there are no canine vaccination campaigns in Ethiopia
from which we could extract epidemiological or economic data. This
meant that our cost estimates were uncertain and potentially biased.
Further, survey-based human rabies case investigation can never be
complete, as not all cases are reported to health centers and thus human
exposures are likely to be underestimated. Higher estimates of human
exposure could justify greater vaccination coverage. Of particular re-
levance, the Ethiopian government plans to replace the nervous tissue
vaccine widely used as a post-exposure prophylactic vaccine with a
safer cell culture vaccine, and there is speculation that the cost of PEP
per case would increase dramatically as a result. Nevertheless, our
analysis found that the recommended coverage remained insensitive to
PEP costs in both districts, which implies that the intended switch
should not impact plans for canine vaccination coverage. Similarly, the
time and resources required to replicate the Tanzanian study aimed to
collect rabies transmission parameters in Ethiopia would be substantial.
Therefore, we conducted a one-way scenario analysis for this para-
meter. The results of the scenario analysis show that high vaccination
coverage is recommended for both districts across a wide range of va-
lues for the biting rate. The recommended vaccination coverage did not
change as changes in the dog-to-human bite rates. The robustness of
recommendations in response to these two parameters is largely due to
the fact that PEP costs are relatively low when compared to the costs of
vaccination programs. On the other hand, the potential improvement in
the level of awareness and use of medical services and a decline in the
use of traditional healers would contribute to an increase in demand of
PEP might lead to expansion of PEP delivery health centres ultimately
leading to lowering the cost of indirect PEP expenditures like trans-
portation to health centers. The impact of opening additional health
centers was not assessed in our sensitivity analysis.
The current practice of killing rabid dogs in Ethiopia was supposed
to reduce the public health burden [16,52]. Killing rabid dogs is ex-
pected to decrease human exposure by preventing dog bites. However,
the lower (0.2) and higher (0.99) rabid dog–to-human bite rates si-
mulated in this study did not appear to alter the recommended vacci-
nation coverage. This reduced sensitivity could be due to the facts that
PEP costs, which are indirectly determined by the bite rate, represent
an insignificant part of the total costs (< 3%). Consequently, killing
rabid dogs might reduce the number of rabid dogs as well as the
number of human exposures but does not affect the optimal canine
vaccination coverage.
We assumed a concerted vaccination campaign applied to all pos-
sible adjacent districts with no risk of reintroduction which would re-
quire a vaccination campaign of larger coverage. In reality re-
introduction of rabies from neighboring areas is one of the key potential
challenges of rabies elimination [53,54]. Accordingly, sensitivity ana-
lysis around the optimal coverage revealed that assuming a re-
introduction rate at an equivalent of 1–2% of rabid cases, increased the
optimal vaccination coverage up to 90%. This reintroduction could be
from neighboring districts and or wild animals. Though we did not
consider wild animals explicitly in the transmission dynamics of rabies
as we had no data on the transmission of wildlife rabies in Ethiopia, the
assumption would not compromise the optimal coverage estimated in
this study as it is unlikely that the wildlife contribution to change the
dynamics significantly, given that as< 1% of human rabies exposures
in Ethiopia are from wild animals in Ethiopia [32,55]. However, there
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could be a potential re-introduction from dogs human-mediated dog
transport from neighboring districts if the campaigns are not consistent
among adjacent districts and or regions. In addition, although intensive
dog vaccination with higher coverage would reduce the rabies in-
cidence in a shorter time, the sustainability of vaccinating dogs should
be ensured which otherwise could lead to re-emergence of the disease.
Based on personal communication with elders in the study areas, people
welcome vaccination initiatives for other reason than the cost of vac-
cination and hence refusal was considered negligible.
The recommended annual coverage of 70% in Bishoftu would re-
quire an average annual budget of $5789 over 5 years of which 99.8%
would go to canine vaccination campaign costs and the rest to PEP
costs. Similarly, in the rural district (Lemuna-bilbilo), an optimal an-
nual coverage of 80% would require on average $20,079 annually over
5 years, of which $19,050 would be for canine vaccination and the rest
for PEP. Knowing that Ethiopia has 529 districts, of which 423 (80%)
are rural districts, the estimate for a national annual canine vaccination
budget would be in the order of $17.5 million; far less than the national
annual loss due to cattle rabies, which is estimated to be $209 million
[18].
A concerted effort to implement our recommended annual vacci-
nation strategy would significantly minimize, if not eliminate, rabid
dogs, and consequently human exposure, as well as a livestock-related
loss within the first few years. One of the reasons for such a low cov-
erage could be the perceived cost of vaccination campaigns and lack of
evidence on the cost-effective level of control. Given the Ethiopian
government determination to meet 2030 WHO plan to eliminate dog
mediated human rabies [56] such economic evaluation would provide a
strong incentive for the immediate action on canine rabies vaccination
in rural Ethiopia, as the entire financial investment will be cost saving.
However, such efforts from a resource-limited country like Ethiopia
with various competing interests would not be possible without inter-
national support. Thus, rabies elimination would require international
and regional collaboration, without which it will not be possible to
eliminate dog-mediated human rabies by 2030 [10]. Studies such as the
one reported here on optimal vaccination coverage such as that re-
ported here are very useful in a resource-scarce setting as higher vac-
cination coverage does not necessarily lead to the best outcome. For
instance, in rural areas of Tanzania, vaccination coverages as high as
90% have been shown to have similar epidemiologic impacts as cov-
erages of 70% [48], implying that vaccination campaigns which aim at
very high levels of coverage may not provide the anticipated payback.
Although, the use of dogs in Ethiopia is predominantly for guarding and
no financial value of dogs were included in our analysis, vaccinating all
dogs would be beneficial for individual dog health and welfare.
One of the limitations of this study relates to the parameter esti-
mates used for transmission from rabid dogs to humans and cattle.
Rabies transmission dynamics were modeled within the domestic dog
population alone, while human and cattle populations were not con-
sidered as contributing to transmission. Other studies have taken a
different approach, making transmission to humans dependent on
human density as well [44]. In our study, the base case transmission
rate from rabid dogs to humans was adopted from empirical observa-
tion in Tanzania [19]. Although we found that the recommendation for
high vaccination coverage is robust to variation in this parameter,
further study into the biting behavior of rabid dogs would improve the
precision of the recommendations. Similarly, cattle rabies was assumed
to be proportionately with canine rabies, such that control of canine
rabies would lead to control of cattle rabies. It is possible that alter-
native hosts are also transmitting rabies to cattle, although none were
observed or anecdotally reported to the field team.
Observational field studies could validate and improve model
output in additional ways. For instance, canine vaccination does not
guarantee the development of protective immunity, and the degree of
protective immunity varies based on the health and nutritional status of
the vaccinated dogs. In addition, diagnostic confirmation of canine
rabies cases would give a more accurate number when compared to the
six diagnostic criteria for biting dogs using retrospectively obtained dog
history [25]. This approach has a number of limitations and laboratory
diagnosis remains the gold standard. However, this method has a sen-
sitivity of 90.2%, a specificity of 96.2% and accuracy of 94.6% for the
clinical diagnosis of rabies, and, therefore, is an appropriate substitute
in settings such as Ethiopia where rabies laboratories are very scarce
and highly centralized. As an additional limitation, we still assumed
homogenous distributions of dogs within each district. More realism
could be achieved by collecting and incorporating data on canine
contact networks, particularly to understand dynamics under high
coverage [57]. Some comparable studies have also shown the break-
even point for costs between mass canine vaccination and human PEP
options [58]. It is likely that the inclusion of livestock costs leads to an
earlier breakeven point for Ethiopia than calculated for a context using
PEP costs alone.
In conclusion, results from this study indicate that a broader eva-
luation of vaccine-preventable diseases, especially zoonotic diseases,
may result in a higher benefit than perceived benefit from saving
human life alone. This has already been demonstrated for other diseases
like brucellosis and Rift Valley Fever elsewhere [59]. In this study, we
demonstrated that canine mass rabies vaccination in Ethiopia will be a
cost-effective means of combating rabies by reducing the human health
burden and by saving costs compared to the status quo of 18% canine
vaccination coverage in urban districts and no vaccination in rural
districts. With a primary focus on human health benefits (preventing
human cases), the cost-effective level of canine vaccination coverages
with minimal cost per DALY averted for the urban and rural district
differed; with the model indicating 70% for the urban district and 50%
for rural the district. With the inclusion of the livestock rabies-related
losses in the rural district, the optimal level of canine vaccination
coverage increased to 80%. This highlights the relevance of applying a
broader perspective when considering rabies burden and the benefits of
canine mass vaccination. This type of cost-effectiveness study is very
useful in resource-scarce settings as higher vaccination coverages do
not necessarily lead to the best result. Vaccination coverage rates of
70% and 80% were identified as the most likely scenarios to provide the
greatest net health benefits at the WHO-recommended willingness-to-
pay threshold over a time frame of 5 years for the Bishoftu and Lemuna-
bilbilo districts respectively.
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